FDA states that it has analyzed this rule in accordance with the principles set forth in Executive Order 12612 , Federalism , and has determined that the rule does not warrant the preparation of a Federalism Assessment .
The Food and Drug Administration has found that there is no need for a Federal Assessment in this situation .